MCQOPTIONS
Saved Bookmarks
| 1. |
Which of the following is the first non-factor prophylactic bypassing agent that was recently approved for haemophilia A patients with and without inhibitors? |
| A. | Tocilizumab |
| B. | Itolizumab |
| C. | Hemilizumab |
| D. | Emicizumab |
| Answer» E. | |